Dublin, Nov. 22, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/zh4t28/drug_delivery)
has announced the addition of the "Drug
Delivery Technologies Market (Metered Dose Inhalers, Needle-Free
Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches,
Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release,
Ocular Implants) - Global Forecasts To 2017" report to their
offering.
The drug delivery technology market is segmented on the basis of
route of administration into nine categories - oral, pulmonary,
transdermal, injectable, ocular, nasal, topical, implantable, and
transmucosal drug delivery; the market is forecast till 2017. Over
the years, drug delivery technologies have grown phenomenally from
plain drug reformulation and release technologies to innovative
platforms that hold a huge potential for the effective delivery of
biologicals and novel drugs.
The global drug delivery market was worth $142.5 billion in the
year 2012. Patent expiries of certain blockbuster drugs, growing
demand for self administration and home healthcare devices, rising
incidence of chronic diseases such as cardiovascular diseases,
diabetes and cancer, growing focus on pediatric and geriatric
patients, and advancing technology are accelerating the growth of
this market. However, drug failures and recalls, and technical
barriers will hamper the growth of this market, to a certain
extent.
Strategic collaborations, self administration and home care drug
delivery devices, and expanding applications of drug delivery into
niche therapeutic areas represent vast opportunities for key
players in this market. The growing number of elderly persons is a
large consumer of home care drug delivery devices. The global
ageing population (above 60 years) is set to increase from 784
million in 2011 to 2 billion by 2050 and 2.8 billion by 2100.
(Source: UN Population Division). An increase in the number of
geriatric patients and rise in demand for convenient drug delivery
options pose major opportunities for the development of innovative
and easy-to-use drug delivery systems.
This research report categorizes the global drug
delivery market into oral, pulmonary, transdermal, injectable,
ocular, nasal, topical, implantable, and transmucosal drug
delivery. These markets are broken down into segments and
sub-segments, providing exhaustive value analysis for 2010, 2011
and 2012, as well as forecast up to 2017. Each of the drug delivery
market is comprehensively analyzed at a granular level by geography
(North America, Europe, Asia, and Rest of the World) to provide
in-depth information on the global scenario.
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Market Overview
4 Global Drug Delivery Market, By Technology
5 Geographic Analysis
6 Competitive Landscape
7 Company Profiles
Companies Mentioned
- 3M Company
- Alkermes, Inc.
- Aptalis Pharma, Inc.
- Baxter International, Inc.
- Becton, Dickinson And Company
- Catalent Pharma Solutions
- Cima Labs
- Dali Medical Devices
- Endo Health Solutions, Inc.
- Foamix
- Johnson & Johnson, Inc.
- Nektar Therapeutics, Inc.
- Optinose As
- Psivida Corporation
- Skyepharma Plc
- Tapemark
- The Dow Chemical Company
- Valeant Pharmaceuticals
- Ypsomed Holding Ag
For more information visit http://www.researchandmarkets.com/research/zh4t28/drug_delivery
About Research and Markets
Research and Markets is the world's leading source for
international market research reports and market data. We provide
you with the latest data on international and regional markets, key
industries, the top companies, new products and the latest
trends.
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Drug Delivery